// App-Quantinova.ai

: A PROSPECTIVE AUDIT OF A PATIENT COHORT PRESCRIBED HYDROXYCHLOROQUINE FOR RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY RHEUMATIC DISEASES IN ORDER TO PRIORITISE RETINOPATHY SCREENING AND ESTIMATE THE NEED FOR DRUG EDUCATION APPOINTMENTS

Researchers

Presenter

  • Brandon Yeo

Principal Investigators

  • Audrey Low

  • Alexandra Chadwick

  • Sarah Wills

Medical Centers

  • The University of Manchester, Faculty of Biology, Medicine and Health, MANCHESTER, United Kingdom

  • Salford Royal NHS Foundation Trust, Salford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Rheumatoid arthritis

  • Diabetic retinopathy

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved